Frontiers, one of the world's largest and fastest growing open-access publishers, announces the launch of a new journal, Frontiers in Bioengineering and Biotechnology.
A broad scope journal covering all specialties, Frontiers in Bioengineering and Biotechnology will provide a single open-access platform for diverse and emerging bioengineering and biotechnology research to be disseminated and discussed.
Frontiers in Bioengineering and Biotechnology will provide an open-science and interactive web platform for the research community to publish high quality and rigorously peer-reviewed articles. Frontiers' real-time and interactive peer-review enables fast, fair and constructive review of a range of article types. With an average of three months from submission to final decision for a paper, articles are published quickly, under the Creative Commons Attribution (CC-BY) license, and are freely available to an international audience.
The 'Frontiers in' series of journals continually grows and evolves according to the needs of research communities. To that end, Frontiers is working closely with the Bioengineering and Biotechnology research community to build an open-access and interdisciplinary journal receptive to the direction and needs of researchers working in these fields.
The initial specialty sections open for submissions are listed below and many more sections will complement this list soon:
- Frontiers in Biomechanics (Editor-in-Chief: Jack Roberts)
- Frontiers in Bionics (Editor-in-Chief: Danilo De Rossi)
- Frontiers in Biomimetics (Editor-in-Chief: Giuseppe Battaglia)
- Frontiers in Computational Physiology and Medicine (Editor-in-Chief: Raimond Winslow)
- Frontiers in ELSI in Science and Genetics (Editor-in-Chief: Dov Greenbaum)
- Frontiers in Fractal Physiology (Editor-in-Chief: Bruce J West)
- Frontiers in Microbiotechnology, Ecotoxicology and Bioremediation (Editors-in-Chief: Matthew Fields, William Hickey, Ji-Dong Gu)
- Frontiers in Synthetic Biology (Editor-in-Chief: Pengcheng Fu)
- Frontiers in Systems Biology (Editors-in-Chief: Hiroaki Kitano, Aldana Maximino, Raina Robeva)
- Frontiers in Systems Microbiology: (Editor-in-Chief: Matthias Hess)
"We are thrilled with the overwhelmingly positive response from the Bioengineering and Biotechnology research communities in taking up the Frontiers publishing model," says Dr. Kamila Markram, co-founder and CEO of Frontiers.
"It is important, now more than ever, for scientists to share research as freely and widely as possible, to track article impact and to develop new collaborations - these and much more will all be made possible on the Frontiers interactive platform," she added.
Authors are welcome to submit any of the following article types to Frontiers in Bioengineering and Biotechnology: Book Review, Classification, Clinical Case Study, Clinical Trial, CPC, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, and Technology Report.
Frontiers and Nature Publishing Group (NPG) have formed a strategic partnership to advance open-science. In collaboration with NPG, Frontiers is bringing its open-science platform for interactive peer review, post-publication evaluation and research networking to all fields in science, medicine and technology. The latest journal to go live as part of this drive is Frontiers in Bioengineering and Biotechnology.
For more information, please visit: http://www.frontiersin.org/bioengineering_and_biotechnology.
About Frontiers
Frontiers, part of the Nature Publishing Group family, is a scholarly open-access publisher and research networking platform. Based in Switzerland, and formed by scientists in 2007, it is one of the largest and fastest growing publishers and its mission is to empower all academic communities to drive research publishing and communication into the 21st century with Open Science tools.
The "Frontiers in" series of journals publish around 500 peer-reviewed articles every month, which receive 5 million monthly views and are supported by over 25,000 editors and reviewers.
Frontiers has formed partnerships with international organizations, such as, the Max Planck Society and the International Union of Immunological Societies (IUIS). For more information, please visit: http://www.frontiersin.org.